A Retrospective Real-World Analysis Demonstrating the Value of Azstarys for Patients With Attention-Deficit Hyperactivity Disorder

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

13 Mar 2023 According to a Corium media release, data from this study will be presented at the National Association of Pediatric Nurse Practitioner's 44th National Conference on Pediatric Health Care (NAPNAP) meeting on Wednesday, March 15 from 12:30 to 1:30 p.m. at the Rosen Shingle Creek in Orlando, FL.
15 Sep 2022 New trial record
13 Sep 2022 According to a Corium International media release, data from this study will be presented in upcoming Psych Congress 2022; Coriums Psych Congress 2022 posters will be presented on Sunday, September 18, and Monday, September 19, from 1:30 to 3:00 pm CDT (2:30 to 4:00 pm EDT) in Hall D of the New Orleans Convention Center.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com